Related Experiment Video
Updated: Jan 27, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
Polyphenols as Modulators of Macrophage Polarization: Mechanisms and Therapeutic Potential in Chronic Inflammatory
Hui Huang1, Biying Fan2, Changhong Wei3
1Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Abstract:
Macrophage polarization between pro-inflammatory M1 and anti-inflammatory M2 phenotypes is pivotal in chronic inflammatory diseases, offering a key therapeutic target. Natural polyphenols exhibit promising immunomodulatory capacity. This review illustrates how polyphenols target key signaling pathways (NF-κB, JAK/STAT, PI3K/Akt, and Notch) to subsequently direct macrophage polarization, and reveals their potential therapeutic effects in chronic inflammatory diseases. The literature was collected from the Web of Science and PubMed databases using relevant search terms, such as "natural polyphenols," "macrophage polarization," "natural products," "signaling pathways," "chronic inflammation," "anti-inflammatory," and "pharmacokinetics." Polyphenols exert their effects by modulating core signaling pathways, with the resultant reprogramming of macrophage polarization being a key consequential event. These compounds primarily promote M2 polarization, thereby resolving chronic inflammatory-related diseases, including atherosclerosis, metabolic diseases, and neurodegenerative diseases. Meanwhile, their ability to induce M1 polarization also provides new intervention strategies for cancer therapy. In addition to overcome the limitations of low bioavailability and low toxicity of polyphenols, this review proposes innovative approaches including nanotechnology, synthetic biology, and artificial intelligence. Polyphenols modulate macrophage polarization via signaling pathways, demonstrating therapeutic duality: promoting M2 polarization to resolve chronic inflammation while inducing M1 polarization for cancer immunotherapy. This insight positions them as promising immunomodulators.
More Related Videos
Related Concept Videos
Potential Due to a Polarized Object
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

